NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Francis Medical

Francis Medical

Private
Maple Grove, MinnesotaHealthcare & Life Scienceshttps://www.francismedical.com/

Last Round

Series C

Jan 7, 2025

Est. Valuation

$230M

Total Funding Raised

$153M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Francis Medical is a medical device company that develops minimally invasive water vapor ablation therapies for the treatment of urological cancers, including prostate, kidney, and bladder cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

water vapor ablationprostate cancer treatmentminimally invasive surgeryVanquish Systemurology medical devicethermal ablationprostate tissue ablationurologyprostate therapyprocedural disposablesurological carevapor therapyurology techminimally invasive urologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Francis Medical Comps

Public and private peers based on sector, stage, and business model.

Francis Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Francis Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 7, 2025
Series BSep 15, 2021
VC RoundSep 29, 2020
Series ADec 13, 2018

Key People

Founding team and executive leadership

Michael Hoey

Founder Director President CTO

Founding Team

Mike Kujak

President, CEO Director

Executive Team

Francis Medical Investors

Notable investors and investment history

Francis Medical investors
InvestorRounds
Tonkawa Inc.Series C
Arboretum VenturesSeries B, Series C, Series A
Orlando Health VenturesSeries C
Boston Scientific CorporationSeries A
Coloplast A/SSeries C, Series B, VC Round
Solas BioVenturesSeries A, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    First commercial use of Vanquish procedure for prostate tissue ablation completed.

  • Jan 7, 2025

    $80M round closed.

Francis Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Francis Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Francis Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMaple Grove, Minnesota
Employee Range76
Year Founded2018
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.